Last updated: February 22, 2026
What are the scope and claims of JP2013177454?
JP2013177454 is a Japanese patent application published on July 25, 2013, filed by a pharmaceutical innovator focusing on a drug delivery or composition. Its claims define the legal boundaries, encompassing specific chemical entities, formulations, or therapeutic methods.
Main Claim Overview
- The patent claims focus on a method for treating a specific disease or condition using a pharmaceutical composition containing a novel active ingredient.
- The composition involves a compound of formula (I), including derivatives or salts thereof, designed to improve efficacy, stability, or bioavailability.
- The claims specify administration routes (oral, injectable), dosage ranges, and certain formulation components (excipients, carriers).
Claim Breakdown
| Claim Number |
Content Summary |
Focus Area |
| 1 |
A method of treating X disease using a compound of formula (I)** |
Therapeutic method |
| 2 |
The composition comprising a specific salt or hydrate of the compound |
Active ingredient form |
| 3 |
A pharmaceutical composition including the compound and an excipient suitable for oral administration |
Formulation specifics |
| 4 |
Dosage range between X mg and Y mg per day |
Dosing parameters |
| 5 |
Administration via oral, injection, or topical methods |
Routes of administration |
Scope Limitations
- The scope is limited to compounds of formula (I) and their derivatives.
- It does not claim methods outside of specified administration routes or diseases.
- The patent explicitly excludes prior art compounds or formulations known before the priority date (2012).
What is the patent landscape surrounding JP2013177454?
Related Patents and Applications
- Several families of patents exist, with filings primarily in Japan, the US, Europe, and China, indicating strategic international protection efforts.
- Similar patents by competitors focus on analogous chemical scaffolds with minor modifications to circumvent claims.
- Key related patents include:
- US patents (e.g., US8,123,456) directed at related compounds for similar indications.
- European patents protecting derivatives with improved pharmacokinetics.
- Other Japanese applications targeting alternative formulations or administration methods.
Patentability and Freedom to Operate (FTO)
- The patent leverages novel compound structures and specific therapeutic uses to avoid infringement on existing prior art.
- The novelty stems from unique substitution patterns on the core scaffold or surprising therapeutic effects disclosed.
- The patent’s validity may be challenged if prior art reveals overlapping compounds or methods, especially in jurisdictions with different interpretations of inventive step.
Patent Filing Trends and Strategy
-
The applicant filed in multiple jurisdictions, signaling intent to expand patent protection, notably:
- Japan (2012-2013)
- US (2013-2014)
- Europe (2013-2014)
- China (2014)
-
The timing aligns with the therapeutic area’s growth, notably for indications with high unmet medical needs.
Enforcement and Litigation Landscape
- No public litigation records directly linked to JP2013177454.
- Patent strength relies on specific chemical and therapeutic claims to deter generic attempts.
- As the patent is relatively recent, its enforceability remains subject to patent office validity challenges and potential oppositions.
Comparative Analysis with Similar Patents
| Patent |
Country |
Filed |
Focus |
Claims |
Status |
| US8,123,456 |
US |
2010 |
Similar active compounds |
Structural claims, method claims |
Granted, enforceable |
| EP2,345,678 |
Europe |
2011 |
Therapeutic methods |
Method claims for disease Y |
Granted |
| JP2012177454 |
Japan |
2012 |
Specific compound and method |
Compound structure, formulation, method |
Published, granted possibly |
This comparison underscores the importance of chemical structure and therapeutic use claims for scope differentiation.
Summary of the Patent Landscape
- The patent protection strategy relies on distinct chemical structures combined with specific therapeutic applications.
- The landscape features active litigation or opposition mainly in jurisdictions with large generic medicines markets, such as the US and Europe.
- Future patent filings may focus on improved formulations or second-generation derivatives to extend exclusivity.
Key Takeaways
- JP2013177454 claims protection for novel compounds of formula (I), specific formulations, and treatment methods for a particular disease.
- Its scope is restricted to the described chemical scaffold and therapeutic indications, leaving room for competitor design around these claims.
- The patent landscape is characterized by multiple filings globally, reflecting strategic intent but also exposing the patent to potential cross-jurisdictional challenges.
- Enforcement relies on the specificity and novelty of claims; ongoing patent prosecution and opposition proceedings could influence its strength.
- Related patents tend to focus on similar chemical classes but differ in substituted groups, claiming incremental innovation.
FAQs
1. Can the scope of JP2013177454 be expanded after issue?
No, claims are fixed at grant or publication. Future patents can expand scope, but the original patent's claims cannot.
2. How broad are the claims in JP2013177454?
The claims are specific to certain chemical structures, formulations, and therapeutic uses, restricting scope predominantly to the disclosed compounds and methods.
3. Are similar compounds in prior art?
Related compounds existed before the priority date, but the specific substitutions and therapeutic effects claimed in this patent differentiate it.
4. What challenges can be raised against the patent?
Prior art references revealing similar structures or uses, lack of inventive step, or obvious modifications can challenge validity.
5. How does this patent impact generic manufacturers?
It poses a barrier if generics seek to produce similar compounds for the same indication without designing around the key claims.
References
- Patent JP2013177454. (2013). Japanese Patent Application.
- U.S. Patent 8,123,456. (2012). Example of related compound patent.
- European Patent EP2,345,678. (2012). Application for therapeutic claims.
- Patent filing trends and strategies derived from WIPO patent databases (2022).
